Our Portfolio

OUTLYER is a pioneering entertainment company redefining inclusive storytelling. Founded by musician and humanitarian Emmanuel Kelly and filmmaker Joanne Reay, the company creates powerful, commercially driven content that amplifies underrepresented voices.

Supported by global partners including Coldplay's Chris Martin and the Oscar-winning visual effects team at DNEG, OUTLYER is developing a slate of six feature films designed to merge purpose with profitability. Headquartered in London and Los Angeles, it unites acclaimed talent with authentic narratives to reflect the diversity of modern audiences.

By combining artistry, innovation, and social impact, OUTLYER aims to prove that meaningful representation and commercial success go hand in hand.

Z2O Technologies is a UK-based environmental biotechnology company transforming how the oil and gas industry approaches sustainability. Using advanced bacterial science, Z2O creates eco-friendly formulations that replace toxic chemicals in cleaning, treatment, and restoration processes.

Its patented solutions break down hydrocarbons and other pollutants, protecting water systems and the environment while improving industrial efficiency. With decades of research in microbiology and field applications, Z2O's technology delivers measurable environmental and operational benefits to clients worldwide.

The company's mission is to accelerate the energy sector's transition toward cleaner, regenerative practices that support both profitability and planetary health.

Koyo HealthTech is an innovative digital health platform focused on improving access to quality healthcare across Africa, beginning with Nigeria. Through its user-friendly app, patients can connect instantly with licensed doctors, receive medical triage, and manage prescriptions remotely.

Koyo addresses one of Africa's most pressing challenges: the shortage of accessible and affordable healthcare. By integrating technology, data, and trusted medical expertise, it reduces the burden on overcrowded clinics and helps patients take control of their wellbeing.

Koyo's vision is to create a more equitable healthcare ecosystem, ensuring that everyone, regardless of location or income, can access timely, reliable medical support.

Epara Skincare is a British luxury beauty brand created to meet the unique skincare needs of women of colour. Founded by entrepreneur Ozohu Adoh, the brand blends African botanicals with cutting-edge science to deliver effective, elegant formulations.

Each product is handcrafted with ethically sourced natural ingredients that address hyperpigmentation, dryness, and uneven skin tone. Epara has earned global acclaim for its refined aesthetic and commitment to representation in luxury beauty.

Stocked by leading retailers including Harrods, Saks Fifth Avenue, and Net-A-Porter, the brand combines heritage, science, and sophistication to empower women through truly inclusive skincare.

Peptilogics is a US biotech company using artificial intelligence to design next-generation peptide therapeutics. Founded in 2013 by scientist Jonathan Steckbeck, the company merges advanced computation with peptide biology to develop medicines that address hard-to-treat infections and resistant bacteria.

Its lead candidate, PLG0206, is in clinical trials for prosthetic joint infection and has received FDA Orphan Drug Designation. Peptilogics' AI-driven platform accelerates drug discovery, enabling the design of novel, safe, and effective therapeutics at unprecedented speed and scale.

Backed by global investors and research institutions, Peptilogics is pioneering a new era of computational drug design aimed at tackling some of the world's most urgent medical challenges.